Cargando…

Identifying the critical states and dynamic network biomarkers of cancers based on network entropy

BACKGROUND: There are sudden deterioration phenomena during the progression of many complex diseases, including most cancers; that is, the biological system may go through a critical transition from one stable state (the normal state) to another (the disease state). It is of great importance to pred...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Juntan, Ding, Dandan, Zhong, Jiayuan, Liu, Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9172070/
https://www.ncbi.nlm.nih.gov/pubmed/35668489
http://dx.doi.org/10.1186/s12967-022-03445-0
_version_ 1784721808647258112
author Liu, Juntan
Ding, Dandan
Zhong, Jiayuan
Liu, Rui
author_facet Liu, Juntan
Ding, Dandan
Zhong, Jiayuan
Liu, Rui
author_sort Liu, Juntan
collection PubMed
description BACKGROUND: There are sudden deterioration phenomena during the progression of many complex diseases, including most cancers; that is, the biological system may go through a critical transition from one stable state (the normal state) to another (the disease state). It is of great importance to predict this critical transition or the so-called pre-disease state so that patients can receive appropriate and timely medical care. In practice, however, this critical transition is usually difficult to identify due to the high nonlinearity and complexity of biological systems. METHODS: In this study, we employed a model-free computational method, local network entropy (LNE), to identify the critical transition/pre-disease states of complex diseases. From a network perspective, this method effectively explores the key associations among biomolecules and captures their dynamic abnormalities. RESULTS: Based on LNE, the pre-disease states of ten cancers were successfully detected. Two types of new prognostic biomarkers, optimistic LNE (O-LNE) and pessimistic LNE (P-LNE) biomarkers, were identified, enabling identification of the pre-disease state and evaluation of prognosis. In addition, LNE helps to find “dark genes” with nondifferential gene expression but differential LNE values. CONCLUSIONS: The proposed method effectively identified the critical transition states of complex diseases at the single-sample level. Our study not only identified the critical transition states of ten cancers but also provides two types of new prognostic biomarkers, O-LNE and P-LNE biomarkers, for further practical application. The method in this study therefore has great potential in personalized disease diagnosis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12967-022-03445-0.
format Online
Article
Text
id pubmed-9172070
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-91720702022-06-08 Identifying the critical states and dynamic network biomarkers of cancers based on network entropy Liu, Juntan Ding, Dandan Zhong, Jiayuan Liu, Rui J Transl Med Research BACKGROUND: There are sudden deterioration phenomena during the progression of many complex diseases, including most cancers; that is, the biological system may go through a critical transition from one stable state (the normal state) to another (the disease state). It is of great importance to predict this critical transition or the so-called pre-disease state so that patients can receive appropriate and timely medical care. In practice, however, this critical transition is usually difficult to identify due to the high nonlinearity and complexity of biological systems. METHODS: In this study, we employed a model-free computational method, local network entropy (LNE), to identify the critical transition/pre-disease states of complex diseases. From a network perspective, this method effectively explores the key associations among biomolecules and captures their dynamic abnormalities. RESULTS: Based on LNE, the pre-disease states of ten cancers were successfully detected. Two types of new prognostic biomarkers, optimistic LNE (O-LNE) and pessimistic LNE (P-LNE) biomarkers, were identified, enabling identification of the pre-disease state and evaluation of prognosis. In addition, LNE helps to find “dark genes” with nondifferential gene expression but differential LNE values. CONCLUSIONS: The proposed method effectively identified the critical transition states of complex diseases at the single-sample level. Our study not only identified the critical transition states of ten cancers but also provides two types of new prognostic biomarkers, O-LNE and P-LNE biomarkers, for further practical application. The method in this study therefore has great potential in personalized disease diagnosis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12967-022-03445-0. BioMed Central 2022-06-06 /pmc/articles/PMC9172070/ /pubmed/35668489 http://dx.doi.org/10.1186/s12967-022-03445-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Liu, Juntan
Ding, Dandan
Zhong, Jiayuan
Liu, Rui
Identifying the critical states and dynamic network biomarkers of cancers based on network entropy
title Identifying the critical states and dynamic network biomarkers of cancers based on network entropy
title_full Identifying the critical states and dynamic network biomarkers of cancers based on network entropy
title_fullStr Identifying the critical states and dynamic network biomarkers of cancers based on network entropy
title_full_unstemmed Identifying the critical states and dynamic network biomarkers of cancers based on network entropy
title_short Identifying the critical states and dynamic network biomarkers of cancers based on network entropy
title_sort identifying the critical states and dynamic network biomarkers of cancers based on network entropy
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9172070/
https://www.ncbi.nlm.nih.gov/pubmed/35668489
http://dx.doi.org/10.1186/s12967-022-03445-0
work_keys_str_mv AT liujuntan identifyingthecriticalstatesanddynamicnetworkbiomarkersofcancersbasedonnetworkentropy
AT dingdandan identifyingthecriticalstatesanddynamicnetworkbiomarkersofcancersbasedonnetworkentropy
AT zhongjiayuan identifyingthecriticalstatesanddynamicnetworkbiomarkersofcancersbasedonnetworkentropy
AT liurui identifyingthecriticalstatesanddynamicnetworkbiomarkersofcancersbasedonnetworkentropy